NewsNew developments on the forefront of intermediate-risk pulmonary embolismAuthor:Jordan Ohlsson, MD, Fellow-In-Training Publish date: September 4, 2024While systemic anticoagulation is the mainstay therapy, select individuals may benefit from more immediate reperfusion. Read More
